Epidermal growth factor receptor is a preferred target for treating Amyloid-β-induced memory loss

Lei Wang, Hsueh Cheng Chiang, Wenjuan Wu, Bin Liang, Zuolei Xie, Xinsheng Yao, Weiwei Ma, Shuwen Du, Yi Zhong

研究成果: Article同行評審

133 引文 斯高帕斯(Scopus)

摘要

Current understanding of amyloid-β (Aβ) metabolism and toxicity provides an extensive list of potential targets for developing drugs for treating Alzheimer's disease. We took two independent approaches, including synaptic-plasticity-based analysis and behavioral screening of synthetic compounds, for identifying single compounds that are capable of rescuing the Aβ-induced memory loss in both transgenic fruit fly and transgenic mouse models. Two clinically available drugs and three synthetic compounds not only showed positive effects in behavioral tests but also antagonized the Aβ oligomers-induced activation of the epidermal growth factor receptor (EGFR). Such surprising converging outcomes from two parallel approaches lead us to conclude that EGFR is a preferred target for treating Aβ-induced memory loss.

原文English
頁(從 - 到)16743-16748
頁數6
期刊Proceedings of the National Academy of Sciences of the United States of America
109
發行號41
DOIs
出版狀態Published - 2012 10月 9

All Science Journal Classification (ASJC) codes

  • 多學科

指紋

深入研究「Epidermal growth factor receptor is a preferred target for treating Amyloid-β-induced memory loss」主題。共同形成了獨特的指紋。

引用此